The Value of Orencia in Rapidly Progressing Rheumatoid Arthritis
NCT03331393 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 265
Last updated 2022-07-06
Summary
The purpose of this study is to investigate the value of Orencia in rapidly progressing Rheumatoid Arthritis (RA).
Conditions
Interventions
- OTHER
-
Non-interventional
Non-interventional
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-03-16
- Primary Completion
- 2019-01-17
- Completion
- 2019-01-17
Countries
- United States
Study Locations
More Related Trials
-
Analysis of T and B Cell Repertoire Changes in Response to Orencia® (Abatacept) in Rheumatoid Arthritis
NCT05782335 ·Status: RECRUITING
-
Assessment of the Effectiveness of IV and SC Abatacept (Orencia) Patient Alert Cards in Patients With Rheumatoid Arthritis in a Sample of EU Countries
NCT02632890 ·Status: COMPLETED
-
Study of the Safety of Orencia in Japanese Children and Adolescents With Active Juvenile Arthritis of Unknown Origin
NCT03466814 ·Status: COMPLETED
-
Korean Post-marketing Surveillance for Orencia®
NCT01583244 ·Status: COMPLETED
-
A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid Arthritis
NCT00134693 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment for Subjects With Active Rheumatoid Arthritis (RA)
NCT00110903 ·Status: COMPLETED ·Phase: PHASE3
-
Effect on Orencia (Abatacept) on the Apoptosis of T Cells, B Cells and APC Cells in Rheumatoid Arthritis
NCT01717846 ·Status: WITHDRAWN ·Phase: PHASE4
-
Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions
NCT00001291 ·Status: COMPLETED
-
Diagnostic Value of Oral Prednisolone Test for Rheumatoid Arthritis
NCT01395251 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of the Safety and Pharmacokinetics of PRO283698 in Patients With Rheumatoid Arthritis
NCT00888745 ·Status: COMPLETED ·Phase: PHASE1
-
Brigham and Women's Rheumatoid Arthritis Sequential Study
NCT01793103 ·Status: ACTIVE_NOT_RECRUITING
-
Electronic and Lab Pre-screening of New Rheumatology Patients With Rheumatoid Arthritis
NCT03843619 ·Status: UNKNOWN
-
An Open-Label Study to Assess the Rate of Failure of an Enbrel® (Etanercept) SureClick™ Auto-injector in Subjects With Rheumatoid Arthritis
NCT00346294 ·Status: COMPLETED ·Phase: PHASE4
-
Ancillary Study to Protocol 20060104
NCT00439894 ·Status: COMPLETED
-
A Study of the Effects of Oral Prednisone in Patients With Rheumatoid Arthritis (MK0000-088)
NCT00746512 ·Status: COMPLETED ·Phase: PHASE1
-
Effects Of Prednisolone On Rheumatoid Arthritis Patients
NCT00330889 ·Status: COMPLETED
-
Assessment of the Clinical and Medico-economic Impact of SinnoTest® in Patients With Rheumatoid Arthritis
NCT04117165 ·Status: WITHDRAWN ·Phase: NA
-
Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid Disorders
NCT00132418 ·Status: COMPLETED ·Phase: PHASE4
-
Enbrel Liquid Immunogenicity Protocol
NCT00249041 ·Status: COMPLETED ·Phase: PHASE3
-
Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis
NCT00989235 ·Status: COMPLETED ·Phase: PHASE3
-
This is a Retrospective Observational Study Looking at the Characteristics and Outcomes of Participants Taking Inflectra Using the CorEvitas Rheumatoid Arthritis Registry
NCT05375942 ·Status: COMPLETED
-
Clinical Study Evaluating the Effect of Carvedilol in Patients With Active Rheumatoid Arthritis
NCT06108518 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Study Evaluating Enbrel in Patients With Rheumatoid Arthritis
NCT00245934 ·Status: COMPLETED
-
A Study of Abatacept in Participants That Only Recently Started to Develop Rheumatoid Arthritis
NCT03457792 ·Status: COMPLETED
-
Circadian RA Study in Rheumatoid Arthritis Subjects
NCT03178955 ·Status: WITHDRAWN